CorMedix Inc. short interest in 2022
In 2022, CorMedix Inc.'s disclosed short interest ran from 4.88% of shares outstanding on 14 Jan 2022 to 3.74% on 30 Dec 2022, a change of -1.14 percentage points. The year's high was 8.75% on 15 Jun 2022 and its low 3.74% on 15 Dec 2022, averaging 5.31% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.96 days on 15 Feb 2022. Full history: CorMedix Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 4.88% (14 Jan 2022)
- End of year
- 3.74% (30 Dec 2022)
- Change
- -1.14 pp
- High
- 8.75% (15 Jun 2022)
- Low
- 3.74% (15 Dec 2022)
- Average
- 5.31%
- Highest days to cover
- 16.96 (15 Feb 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 4.88% | 13.80 | |
| 31 Jan 2022 | 5.21% | 10.35 | |
| 15 Feb 2022 | 5.45% | 16.96 | |
| 28 Feb 2022 | 5.55% | 9.25 | |
| 15 Mar 2022 | 6.04% | 7.77 | |
| 31 Mar 2022 | 6.24% | 4.88 | 10-K filed, results (8-K) |
| 14 Apr 2022 | 6.59% | 10.10 | |
| 29 Apr 2022 | 7.41% | 6.94 | |
| 13 May 2022 | 7.76% | 9.34 | 10-Q filed, results (8-K) |
| 31 May 2022 | 8.23% | 8.47 | |
| 15 Jun 2022 | 8.75% | 8.45 | |
| 30 Jun 2022 | 5.53% | 2.66 | |
| 15 Jul 2022 | 5.18% | 6.27 | |
| 29 Jul 2022 | 5.17% | 5.71 | |
| 15 Aug 2022 | 4.38% | 1.38 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 4.15% | 6.43 | |
| 15 Sep 2022 | 3.95% | 9.59 | |
| 30 Sep 2022 | 4.01% | 8.91 | |
| 14 Oct 2022 | 3.79% | 11.10 | |
| 31 Oct 2022 | 3.98% | 14.23 | |
| 15 Nov 2022 | 3.97% | 5.29 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 3.78% | 6.85 | |
| 15 Dec 2022 | 3.74% | 7.28 | |
| 30 Dec 2022 | 3.74% | 7.39 |
See also: CorMedix Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.